Nuts, blood lipids and cardiovascular disease

Asia Pacific Journal of Clinical Nutrition

Volumn 19, Issue 1, 2010, Pages 131-136

  Sabaté, Joan ^a   Wien, Michelle ^a  

^a LOMA LINDA UNIVERSITY   (United States)

Author keywords

Blood lipids; Cardiovascular disease; Cholesterol; Fatty acids; Nuts

Indexed keywords

FATTY ACID; LIPID; LIPOPROTEIN;

ANIMAL; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CHEMISTRY; COMPARATIVE STUDY; DIET; DIET THERAPY; FOOD ANALYSIS; HUMAN; HYPERCHOLESTEROLEMIA; NUT; NUTRITIONAL VALUE; SPECIES DIFFERENCE;

ANIMALS; CARDIOVASCULAR DISEASES; DIET; FATTY ACIDS; FOOD ANALYSIS; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; LIPOPROTEINS; NUTRITIVE VALUE; NUTS; SPECIES SPECIFICITY;

EID: 77952308334     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Kris-Etherton PM, Yu-Poth S, Sabate J, Ratcliffe HE, Zhao G, Etherton TD. Nuts and their bioactive constituents: effects on serum lipids and other factors that affect disease risk. Am J Clin Nutr. 1999;70:S504-11.
2. Mukuddem-Petersen J, Oosthuizen W, Jerling J. A systematic review of the effects of nuts on blood lipid profiles in humans. J Nutr. 2005;135:2082-9.
3. Hu FB, Stampfer MJ. Nut consumption and risk of coronary heart disease: a review of epidemiologic evidence. Curr Atheroscler Rep. 1999;1:204-9.
4. Sabaté J, Radak T, Brown Jr. J. The role of nuts in cardiovascular disease prevention. In: Wildman R, ed. Handbook of Nutraceuticals and Functional Foods. Boca Raton: CRC Press; 2001. pp. 486-91.
5. US Food and Drug Administration. Qualified Health Claims: Letter of Enforcement Discretion - Nuts and Coronary Heart Disease. Rockville, MD: US Food & Drug Adminstration. 2003/7/14 [cited 2010/2/8]; Available from: http://www.fda.gov/Food/LabelingNutrition/LabelClaims/QualifiedHealthClaims/ucm072926.htm.
6. Fraser GE, Sabate J, Beeson WL, Strahan TM. A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist Health Study. Arch Intern Med. 1992; 152:1416-24.
7. Sabate J. Nut consumption, vegetarian diets, ischemic heart disease risk, and all-cause mortality: evidence from epidemiologic studies. Am J Clin Nutr. 1999;70:S500-3.
8. Fraser GE, Shavlik DJ. Risk factors for all-cause and coronary heart disease mortality in the oldest-old. The Adventist Health Study. Arch Intern Med. 1997;157:2249-58.
9. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med. 1996;334:1156-62.
10. Hu FB, Stampfer MJ, Manson JE, Rimm EB, Colditz GA, Rosner BA, Speizer FE, Hennekens CH, Willett WC. Frequent nut consumption and risk of coronary heart disease in women: prospective cohort study. BMJ. 1998;317:1341-5.
11. Albert CM, Gaziano JM, Willett WC, Manson JE. Nut consumption and decreased risk of sudden cardiac death in the Physicians' Health Study. Arch Intern Med. 2002;162:1382-7.
12. Kelly JH, Sabate J. Nuts and coronary heart disease: an epi-demiological perspective. Br J Nutr. 2006;96:S61-7.
13. Kris-Etherton PM, Hu FB, Ros E, Sabate J. The role of tree nuts and peanuts in the prevention of coronary heart disease: multiple potential mechanisms. J Nutr. 2008;138:S1746-51.
14. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5:1113-24.
15. Sabate J, Jenab M, Ferrari P, Norat T, Slimani N, Riboli E on behalf of the EPIC Group. Nut consumption and protection against coronary heart disease in the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur Heart J. 2006;27:270.
16. Sabate J, Fraser GE, Burke K, Knutsen SF, Bennett H, Lind-sted KD. Effects of walnuts on serum lipid levels and blood pressure in normal men. N Engl J Med. 1993;328:603-7.
17. Sabate J, Haddad E, Tanzman JS, Jambazian P, Rajaram S. Serum lipid response to the graduated enrichment of a Step I diet with almonds: a randomized feeding trial. Am J Clin Nutr. 2003;77:1379-84.
18. Jenkins DJ, Kendall CW, Marchie A, Parker TL, Connelly PW, Qian W et al. Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial. Circulation. 2002;106:1327-32.
19. Griel AE, Kris-Etherton PM. Tree nuts and lipid profile: a review of clinical studies. Br J Nutr. 2006;96 (suppl):68-78.
20. Ros E. Nuts: consumption, composition, health benefits and safety. CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources. 2008;3:1-12.
21. Sabate J, Oda K, Ros E. Nut consumption and blood lipids: a pooled analysis of 25 intervention trials. Arch Intern Med. (in press)
22. Banel DK, Hu FB. Effects of walnut consumption on blood lipids and other cardiovascular risk factors: a meta-analysis and systematic review. Am J Clin Nutr. 2009;90:56-63.
23. Kaminski WE, Jendraschak E, Kiefl R, von Schacky C. Dietary omega-3 fatty acids lower levels of platelet-derived growth factor mRNA in human mononuclear cells. Blood. 1993;81:1871-9.
24. Calder PC, Albers R, Antoine JM, Blum S, Bourdet-Sicard R, Ferns GA, et al. Inflammatory disease processes and interactions with nutrition. Br J Nutr. 2009;101:S1-45.
25. Exler J, Weihrauch J. Provisional Table on the Content of Omega-3 Fatty Acids and Other Fat Components in Selected Foods. Publication HNIS/PT-103. Washington, DC. US Department of Agriculture. 1986.
26. Huynh NN, Chin-Dusting J. Amino acids, arginase and nitric oxide in vascular health. Clin Exp Pharmacol Physiol. 2006;33:1-8.
27. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med. 1995;333:276-82.
28. Jenkins DJ, Wolever TM, Spiller G, Buckley G, Lam Y, Jenkins AL, Josse RG. Hypocholesterolemic effect of vegetable protein in a hypocaloric diet. Atherosclerosis. 1989;78:99-107.
29. Salas-Salvado J, Bullo M, Perez-Heras A, Ros E. Dietary fibre, nuts and cardiovascular diseases. Br J Nutr. 2006;96: S46-51.
30. Fraser G. Nut consumption, lipids, and risk of a coronary event. Asia Pac J Clin Nutr. 2000;9:S28-32.
31. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med. 1998;338:1042-50.
32. Champagne CM. Magnesium in hypertension, cardiovascular disease, metabolic syndrome, and other conditions: a review. Nutr Clin Pract. 2008;23:142-51.
33. Houtman JP. Trace elements and cardiovascular diseases. J Cardiovasc Risk. 1996;3:18-25.
34. Wagner KH, Kamal-Eldin A, Elmadfa I. Gamma-tocopherol-an underestimated vitamin? Ann Nutr Metab. 2004;48:169-88.
35. Dreher ML, Maher CV, Kearney P. The traditional and emerging role of nuts in healthful diets. Nutr Rev. 1996;54: 241-5.
36. Haddad E, Sabate J, Whitten C. Vegetarian food guide pyramid: a conceptual framework. Am J Clin Nutr. 1999;70: S615-9.
37. US Department of Health and Human Services. The DASH Diet. US Department of Health and Human Services. NIH Publication no. 98-4082. Bethesda, MD. National Institutes of Health. 1998.
38. National Heart, Lung, Blood Institute. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Executive Summary. Bethesda, MD. National Institutes of Health. 2001.